ArticlePharmacoEconomics2020

We are Not Meeting the Needs of Pharmacoeconomic Models of Nonalcoholic Steatohepatitis, But We Can.

Elliot B Tapper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.